Dark Forest Capital Management LP Biogen Inc. Transaction History

Dark Forest Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $8,176 - $11,275	42 New	42 $11,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $2,813 - $3,345	-15 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $1,550 - $1,953	-8 Reduced 34.78%	15 $3,000
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $5,150 - $6,618	23 New	23 $6,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.